Combination of deferasirox and deferoxamine in management of iron overload in myelodysplastic syndromes (MDS): An update in a hepatopatic patient

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Pugliese, N. [1 ]
Marano, L. [1 ]
Vitagliano, O. [1 ]
Matarazzo, M. [2 ]
Pane, F. [1 ]
Alfinito, F. [1 ]
机构：
[1] Univ Naples Federico II, Hematol, Naples, Italy
[2] Univ Naples Federico II, Clincal Med, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70235-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-187
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [22] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
  • [23] Iron overload in myelodysplastic syndromes
    Mahesh, Sameer
    Ginzburg, Yelena
    Verma, Amit
    LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 427 - 438
  • [24] Iron overload in myelodysplastic syndromes
    Chodirker, Lisa
    Wells, Richard A.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (03) : 215 - 218
  • [25] Iron overload and myelodysplastic syndromes
    Calvet, Laure
    HEMATOLOGIE, 2010, 16 : 21 - 24
  • [26] THE EFFECT OF DEFERASIROX IN THE PLATELETS ACTIVATION AND THE ATHEROTHROMBOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) AND IRON OVERLOAD.
    Garcia, Regina
    Caparros, Isabel
    Isabel Rossell, Ana
    Campos, Arturo
    Paz Queipo de LLano, Maria
    Ramirez, Gemma
    Del Castillo, Santiago
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 431 - 432
  • [27] Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major
    Ladis, Vassilis
    Kyriacopoulou, Dimitra
    Stokidis, Konstantinos
    Moira, Aggeliki
    Kattamis, Antonios
    BLOOD, 2012, 120 (21)
  • [28] Sequential Deferoxamine - Deferasirox in Treatment of Major Thalassemia with Iron Overload
    Keikhaei, B.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 1 (01) : 14 - 18
  • [29] Pathogenesis of iron overload in myelodysplastic syndromes and the debate on iron chelation in low-risk MDS
    Shenoy, Niraj
    Verma, Amit
    Ginzburg, Yelena
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S85 - S85
  • [30] Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes
    Greenberg, Peter L.
    Koller, Charles A.
    Cabantchik, Z. Ioav
    Warsi, Ghulam
    Glynos, Tara
    Paley, Carole
    Schiffer, Charles
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1560 - 1565
12345